Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · IEX Real-Time Price · USD
9.92
-0.93 (-8.57%)
At close: May 6, 2024, 4:00 PM
9.95
+0.03 (0.30%)
After-hours: May 6, 2024, 7:53 PM EDT
Sera Prognostics Revenue
In the year 2023, Sera Prognostics had annual revenue of $306.00K with 14.18% growth. Revenue in the quarter ending December 31, 2023 was $41.00K, a -36.92% decrease year-over-year.
Revenue (ttm)
$306.00K
Revenue Growth
+14.18%
P/S Ratio
1,026.78
Revenue / Employee
$5,564
Employees
55
Market Cap
314.20M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 306.00K | 38.00K | 14.18% |
Dec 31, 2022 | 268.00K | 186.00K | 226.83% |
Dec 31, 2021 | 82.00K | 57.00K | 228.00% |
Dec 31, 2020 | 25.00K | -11.00K | -30.56% |
Dec 31, 2019 | 36.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Clover Health Investments | 2.03B |
Zynex | 188.68M |
Esperion Therapeutics | 116.33M |
Contineum Therapeutics | 50.00M |
Caribou Biosciences | 34.48M |
Precigen | 6.23M |
Ocugen | 6.04M |
Atai Life Sciences | 314.00K |
SERA News
- 7 days ago - Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024 - PRNewsWire
- 6 weeks ago - SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024 - PRNewsWire
- 2 months ago - Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference - PRNewsWire
- 5 months ago - SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS - PRNewsWire
- 5 months ago - SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE - PRNewsWire
- 6 months ago - SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS - PRNewsWire
- 6 months ago - Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023 - PRNewsWire